https://www.targetedonc.com/view/duration-of-response-with-xevinapant-plus-standard-chemoradiation-in-la-scchn
Jean Bourhis, MD, discusses results from the phase 2 study of xevinapant plus chemoradiation vs placebo and chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck.
Create an account
or login to join the discussion